6.4 Indications & Timing for Induction of Labor
Key Takeaways
- Routine induction is recommended between 41 0/7 and 42 0/7 weeks and should not be delayed beyond 42 0/7 weeks.
- The ARRIVE trial randomized 6,106 low-risk nulliparas and found elective induction at 39 weeks reduced cesarean birth from 22.2 to 18.6 percent and hypertensive disorders from 14.1 to 9.1 percent.
- Elective induction before 39 0/7 weeks remains contraindicated because of neonatal respiratory morbidity.
- In fetal growth restriction, absent end-diastolic umbilical artery flow warrants delivery at 33 to 34 weeks and reversed end-diastolic flow warrants delivery at 30 to 32 weeks.
- Absolute contraindications to induction include prior classical or T-shaped hysterotomy, complete placenta previa or vasa previa, active genital herpes lesions, transverse lie, and cord prolapse.
Quick Summary: Induction of labor is indicated when the risks of continuing the pregnancy outweigh the risks of birth, and each condition carries its own gestational-age target. This section covers the medically indicated conditions and their timing, the ARRIVE trial evidence behind elective induction at 39 weeks, and the absolute contraindications. Cervical preparation, oxytocin, and amniotomy follow in the next two sections.
Indications & Timing for Induction of Labor
Induction of labor is indicated when the maternal or fetal risks of continuing the pregnancy outweigh the potential risks of labor induction and delivery.
Medically Indicated Labor Induction
Common evidence-based indications and their recommended gestational timing established by the American College of Obstetricians and Gynecologists (ACOG) and the Society for Maternal-Fetal Medicine (SMFM) include:
- Postterm & Late-Term Pregnancy: Late-term pregnancy spans 41 0/7 to 41 6/7 weeks; postterm pregnancy is defined as ≥ 42 0/7 weeks. Perinatal mortality, stillbirth, oligohydramnios, meconium aspiration syndrome, and macrosomia rise steadily past 41 weeks. Routine labor induction is strongly recommended between 41 0/7 and 42 0/7 weeks, and should not be delayed beyond 42 0/7 weeks.
- Preeclampsia & Gestational Hypertension: For gestational hypertension or preeclampsia without severe features, induction is indicated at 37 0/7 weeks. In the presence of severe features (e.g., persistent severe blood pressure ≥ 160/110 mmHg, platelets < 100,000/mcL, elevated transaminases, progressive renal insufficiency, pulmonary edema, or intractable neurological symptoms), delivery is indicated at 34 0/7 weeks, or immediately upon maternal stabilization at any gestational age.
- Prelabor Rupture of Membranes (PROM) at Term: At ≥ 37 0/7 weeks, labor induction with oxytocin significantly reduces the latency period and maternal infectious morbidity (chorioamnionitis, endometritis) compared to expectant management, without increasing the cesarean delivery rate.
- Oligohydramnios: An amniotic fluid index (AFI) < 5 cm or maximum vertical pocket (MVP) < 2 cm at term (≥ 37 0/7 weeks) warrants labor induction due to increased risks of cord compression, placental senescence, and fetal compromise.
- Gestational Diabetes Mellitus (GDM): In well-controlled, diet-managed A1GDM, expectant management up to 40 6/7 weeks is appropriate. For medically managed A2GDM on insulin or oral hypoglycemics with good glycemic control, induction is recommended between 39 0/7 and 39 6/7 weeks. Poorly controlled GDM may require earlier delivery (37 0/7 to 38 6/7 weeks).
- Fetal Growth Restriction (FGR): Estimated fetal weight (EFW) or abdominal circumference < 10th percentile. If accompanied by abnormal umbilical artery Doppler velocimetry (decreased end-diastolic velocity), delivery is typically indicated at 37 0/7 weeks; absent end-diastolic flow (AEDF) warrants delivery at 33–34 weeks; reversed end-diastolic flow (REDF) necessitates immediate delivery (often via cesarean) at 30–32 weeks.
- Other Indications: Chorioamnionitis (immediate induction/delivery regardless of gestational age), placental abruption (hemodynamically stable without severe fetal compromise), and medically stable chronic medical conditions (renal disease, systemic lupus erythematosus).
Elective Induction of Labor at 39 Weeks: The ARRIVE Trial
Historically, elective induction in nulliparous women was thought to double the risk of cesarean delivery compared to spontaneous labor. However, this observational comparison suffered from an inherent methodological flaw: comparing women induced at a specific gestational age to women delivering spontaneously at that same age, rather than to women managed expectantly (many of whom later required medically indicated inductions or cesarean sections post-dates).
The ARRIVE Trial (A Randomized Trial of Induction Versus Expectant Management, Grobman et al., NEJM 2018) addressed this question by randomizing 6,106 low-risk nulliparous women between 39 0/7 and 39 4/7 weeks to either elective induction of labor or expectant management:
| Outcome Parameter | Elective Induction at 39 Weeks | Expectant Management Group | Relative Risk / Significance |
|---|---|---|---|
| Primary Cesarean Delivery Rate | 18.6% | 22.2% | RR 0.84 (95% CI 0.76–0.93); Statistically significant reduction |
| Gestational Hypertensive Disorders | 9.1% | 14.1% | RR 0.64 (95% CI 0.56–0.74); Statistically significant reduction |
| Adverse Perinatal Composite | 4.3% | 5.4% | RR 0.80 (95% CI 0.64–1.00); No significant difference |
| Neonatal Respiratory Support | 3.0% | 4.2% | Statistically significant reduction |
| Maternal Pain & Labor Agency | Reported lower perceived labor pain and higher sense of control | Standard labor experience | Enhanced maternal satisfaction scores |
Midwifery Practice Note: ACOG and ACNM affirm that elective induction of labor at 39 0/7 to 39 4/7 weeks in low-risk nulliparous women is a reasonable, evidence-based option that must be offered through shared decision-making. Elective induction prior to 39 0/7 weeks remains strictly contraindicated due to elevated neonatal respiratory morbidity.
Absolute Contraindications to Labor Induction
- Prior classical, T-shaped, or inverted-T hysterotomy incision, or prior extensive transfundal myomectomy entering the uterine cavity.
- Complete placenta previa or vasa previa.
- Active genital herpes simplex virus (HSV) infection with visible lesions or prodromal symptoms.
- Transverse fetal lie or unstable malpresentation.
- Umbilical cord prolapse or funic presentation.
- Invasive cervical carcinoma.
- Severe cephalopelvic disproportion.
A healthy nulliparous patient at 39 1/7 weeks with a singleton vertex fetus and no medical complications asks about elective induction. Which counseling is most consistent with current evidence?